Should You Buy Regulus (RGLS) After Golden Cross?

Core Insights - Regulus Therapeutics Inc. (RGLS) has reached a significant support level, indicating a potential investment opportunity from a technical perspective [1] - The recent breakout of RGLS's 50-day simple moving average above its 200-day moving average signifies a "golden cross," which is a bullish indicator [1] - RGLS has experienced a substantial price increase of 97.7% over the last four weeks, suggesting strong upward momentum [3] Technical Analysis - A golden cross event consists of three stages: the stock price bottoms out, the shorter moving average crosses above the longer moving average, and the stock maintains upward momentum [2] - The occurrence of a golden cross is contrasted with a death cross, which indicates potential bearish price movement [2] Earnings Expectations - RGLS's earnings expectations have shown positive changes, with two upward revisions and no downward revisions in the last 60 days, enhancing the bullish outlook [3] - The Zacks Consensus Estimate for RGLS has also moved upward, further supporting the positive sentiment around the stock [3] Investment Consideration - Given the technical indicators and positive earnings estimate movements, RGLS is recommended for investors to consider adding to their watchlist [5]